Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Lines”

749 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 749 results

Not applicableStudy completedNCT02043145
What this trial is testing

Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea

Who this might be right for
HyperhidrosisMuscle SpasticityGlabellar Lines
Allergan 727
Post-approval studies (Phase 4)Study completedNCT05840445
What this trial is testing

Efficacy of Prabotulinum and Onabotulinum Toxin-A for Facial Wrinkles

Who this might be right for
FaceSkin FoldRejuvenation
Instituto de Oftalmología Fundación Conde de Valenciana 26
Early research (Phase 1)Active Not RecruitingNCT04540900
What this trial is testing

A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions

Who this might be right for
Skin RoughnessWrinkleFine Lines+1 more
Krystal Biotech, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT00445406
What this trial is testing

Bevacizumab and Doxorubicin Hydrochloride Liposome in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Swiss Cancer Institute 43
Testing effectiveness (Phase 2)UnknownNCT04979585
What this trial is testing

Camrelizumab Plus Amlotinib and Chemotherapy in the First-line Treatment of Melanoma

Who this might be right for
Melanoma
Di Wu 66
Very early researchStudy completedNCT00486421
What this trial is testing

Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura

Who this might be right for
Nonneoplastic Condition
Mayo Clinic 22
Not applicableStudy completedNCT00898014
What this trial is testing

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Institut Curie 216
Testing effectiveness (Phase 2)UnknownNCT05438706
What this trial is testing

A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-negative Breast Cancer
Fudan University 70
Testing effectiveness (Phase 2)Study completedNCT02162719
What this trial is testing

A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors

Who this might be right for
Breast Neoplasms
Genentech, Inc. 124
Large-scale testing (Phase 3)UnknownNCT02383030
What this trial is testing

Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients

Who this might be right for
Metastatic Breast Cancer
Consorzio Oncotech 156
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Not applicableStudy completedNCT06003114
What this trial is testing

Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Organs

Who this might be right for
Breast Cancer
Pfizer 472
Post-approval studies (Phase 4)Study completedNCT00856414
What this trial is testing

Patient Satisfaction With Treatment of BOTOX® Cosmetic for the Temporary Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Skin Aging
Allergan 45
Large-scale testing (Phase 3)Ended earlyNCT00097344
What this trial is testing

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasms, Hormone-Dependent
Intarcia Therapeutics 842
Post-approval studies (Phase 4)Study completedNCT01593332
What this trial is testing

Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis

Who this might be right for
DMARD Resistant Rheumatoid Arthritis
Mashhad University of Medical Sciences 44
Not applicableStudy completedNCT06607601
What this trial is testing

CARE Initiative: Real-world Emulation of the PALOMA-2 Trial

Who this might be right for
Metastatic Breast Cancer
Aetion, Inc. 724
Not applicableStudy completedNCT01745757
What this trial is testing

Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer

Who this might be right for
MetastaticBreast Cancer
UNICANCER 510
Not applicableStudy completedNCT05853432
What this trial is testing

A Descriptive Study of Baseline Characteristics, Clinical Outcomes, and Treatment Patterns of HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Alpelisib Plus Fulvestrant Who Have Received Fulvestrant in Any Prior Line of Therapy

Who this might be right for
HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 157
Not applicableEnrolling By InvitationNCT05074212
What this trial is testing

Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee

Who this might be right for
Wound HealWound of Skin
University of California, Davis 172
Large-scale testing (Phase 3)Study completedNCT00002544
What this trial is testing

Mitoxantrone With or Without Docetaxel in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Arbeitsgemeinschaft fur Internistische Onkologie 300
Load More Results